Diagnostic Accuracy and Efficiency

The difference of setting the patient on the right clinical path through timely and accurate diagnosis

Form from the top

Overview
Related Products

Poor diagnostic results can lead to improper diagnoses, delays in treatment or other consequences

12 million

Adults are affected by outpatient diagnostic errors in the United States annually⁶
Up to 75%

Of lab diagnostic errors occur in the preanalytical phase ^7,8
30–50%

Of all antibiotics prescribed aren't needed or aren't optimally effective as prescribed ^9,11

To set patients on the right clinical path, a timely and accurate diagnosis is crucial

With access to high-quality results in less time, clinicians can feel confident that accurate information is informing a more optimal diagnosis and treatment plan. Discover how the right results can lead to a shorter length of stay and a better experience for everyone.

Explore the BD^® Diagnostic Accuracy and Efficiency Program

Overview

Technologies

Goals

Approach

The BD^® Diagnostic Accuracy and Efficiency Program can help you optimize the process from specimen collection through the delivery of lab results and recommends BD solutions to help you minimize errors and complications, like specimen contamination and retesting.

Through our BD^® Diagnostic Accuracy and Efficiency Program, we use a baseline assessment to provide recommendations on BD solutions that can address identified gaps and improve performance in people, processes and technologies. Our technologies are designed to drive better outcomes from preparation through reporting results.

Toward better results

Reducing lab turnaround time and emergency department (ED) length of stay
Minimizing specimen contamination rate
Improving patient and healthcare worker experience
Maximizing diagnostic accuracy

Actionable insights from an industry leader

Reviewing current practices and policies through clinical assessments from specimen collection through delivery of lab results
Providing recommendations based on a baseline assessment of how BD solutions can address identified gaps and improve performance in people, processes and technologies
Helping clinicians adhere to best practice through training and education

Discover how to help set patients on the right clinical path

Prep

Collect

Analyze

Report

<p>Proper cleaning and decontamination of a patient's skin, such as before providing a urine sample or drawing a blood sample, helps reduce contamination rates. 44% of ER patients and inpatients were prescribed inappropriate antibiotics due to contaminated urine cultures.<sup>1</sup></p>
<p><span class="forward-arrow-icon"><a href="/content/bd-com/na/us/en-us/products-and-solutions/products/product-families/chloraprep-swabstick.html">BD ChloraPrep™ swabstick </a><span class="boostedblue-font-color"></span></span></p>

Proper cleaning and decontamination of a patient's skin, such as before providing a urine sample or drawing a blood sample, helps reduce contamination rates. 44% of ER patients and inpatients were prescribed inappropriate antibiotics due to contaminated urine cultures.¹

BD ChloraPrep™ swabstick

The specimen collection method can impact specimen integrity.

56% of blood collections are from patients with diagnoses associated with difficult venous access² (e.g., cancer, chronic cardiovascular disease, chronic kidney disease, diabetes, blood disorders/anemias and obesity).

BD Vacutainer^® UltraTouch™ push button blood collection set

<p>The testing method, timing and process can impact the time to reporting. A 10-minute reduction in lab result turnaround time = 6.7 minute reduction in ED length of stay.<sup>4 </sup></p>
<p><a href="/content/bd-com/na/us/en-us/products-and-solutions/products/product-families/bd-bactec-fx-blood-culture-system.html" target="_blank" rel="noopener noreferrer"><span class="forward-arrow-icon-boosted-blue"><span class="boostedblue-font-color">BD BACTEC™ FX blood culture system</span></span></a></p>
<p><a href="https://go.bd.com/FACSLyric-system.html" target="_blank" rel="noopener noreferrer"><span class="boostedblue-font-color"><span class="forward-arrow-icon-boosted-blue">BD FACSLyric™ clinical flow cytometry system</span></span></a></p>
<p><a href="/content/bd-com/na/us/en-us/products-and-solutions/products/product-families/bd-kiestra-total-lab-automation-tla-system.html"><span class="forward-arrow-icon-boosted-blue"><span class="boostedblue-font-color">BD Kiestra™ lab automation solutions</span></span></a></p>
<p><a href="/content/bd-com/na/us/en-us/products-and-solutions/products/product-families/bd-max-system.html"><span class="boostedblue-font-color"><span class="forward-arrow-icon-boosted-blue">BD MAX™ system</span></span></a></p>
<p><a href="/content/bd-com/na/us/en-us/products-and-solutions/products/product-families/bd-phoenix-m50-instrument.html"><span class="forward-arrow-icon-boosted-blue"><span class="boostedblue-font-color">BD Phoenix™ automated identification and susceptibility testing system</span></span></a></p>
<p><a href="https://bdveritor.bd.com/en-us" target="_blank" rel="noopener noreferrer">BD Veritor™ System</a></p>
<p><a href="https://cervicalcancer.bd.com/products-cor.html" target="_blank" rel="noopener noreferrer">BD COR™ System</a></p>

The testing method, timing and process can impact the time to reporting. A 10-minute reduction in lab result turnaround time = 6.7 minute reduction in ED length of stay.⁴

BD BACTEC™ FX blood culture system

BD FACSLyric™ clinical flow cytometry system

BD Kiestra™ lab automation solutions

BD MAX™ system

BD Phoenix™ automated identification and susceptibility testing system

BD Veritor™ System

BD COR™ System

<p>Time to reporting of results can have an impact on clinical decisions and therefore patient treatment. Many physicians surveyed believed that laboratory turnaround time caused delayed ED treatment more than 50% of the time and increased ED length of stay more than 50% of the time.<sup>5</sup></p>
<p><a href="https://medmined.bd.com/" target="_blank" rel="noopener noreferrer"><span class="forward-arrow-icon-boosted-blue"><span class="boostedblue-font-color">BD MedMined™ Surveillance Advisor</span></span></a></p>
<p><a href="/content/bd-com/na/us/en-us/products-and-solutions/products/product-families/bd-synapsys-informatics-solution.html" target="_blank" rel="noopener noreferrer"><span class="boostedblue-font-color"><span class="forward-arrow-icon-boosted-blue">BD Synapsys™ Microbiology Informatics Solution</span></span></a></p>

Time to reporting of results can have an impact on clinical decisions and therefore patient treatment. Many physicians surveyed believed that laboratory turnaround time caused delayed ED treatment more than 50% of the time and increased ED length of stay more than 50% of the time.⁵

BD MedMined™ Surveillance Advisor

BD Synapsys™ Microbiology Informatics Solution

BD Vacutainer^® UltraTouch™ push button blood collection set

With propriety BD PentaPoint™ and BD RightGauge™ needle technology, the BD Vacutainer^® UltraTouch™ push button blood collection set aims to improve the patient experience by enhancing comfort, enabling clinicians to better access difficult veins, and reducing overall procedure times.

Learn More
Urine Specimen Collection

BD urine specimen kits offer a closed system that reduces the risk of specimen contamination and associated false readings.

Learn More
BD Vacutainer^® blood collection tubes

BD is the inventor of BD Vacutainer^® blood collection tubes as well as the worldwide leader in blood tubes. We support our products with extensive clinical expertise and educational materials to help you achieve the best possible results.

Learn More

BD BACTEC™ FX blood culture system

The BD BACTEC™ FX blood culture system builds on the proven history of previous BD BACTEC™ instrumentation, with advanced fluorescence detection technology, exceptional media performance and instrument reliability—adding vial-activated workflow, advanced ergonomics, blood culture observation and customer-focused data management.

Learn More
BD Kiestra™ InoqulA sample processor

The specimen processor automates the processing of both liquid and non-liquid sample types.

Learn More
BD Kiestra™ ReadA

Intelligent incubation and imaging system. Standardize incubation, imaging and results interpretation.

Learn More
BD Kiestra™ Total Lab Automation (TLA) System

Scalable solution to help you enhance laboratory operations and advance laboratory operations.

Learn More
BD Kiestra™ Urine Culture Application

An application developed with Artificial Intelligence (AI) that enables high resolution and standardized plate imaging to deliver laboratory efficiencies and advanced image analysis.

Learn More
BD Kiestra™ Work Cell Automation (WCA) System

A modular, automated solution designed for microbiology laboratories of all sizes.

Learn More
BD MAX™ system

The BD MAX™ system offers you an efficient path to improved clinical outcomes by combining and automating extraction and thermocycling into a single platform capable of running both FDA-cleared and open system assays. Flexibility and standardization allow you to address the breadth of your testing needs.

Learn More
BD Phoenix™ M50 instrument

The BD Phoenix™ M50 instrument provides clinicians with accurate and timely identification and susceptibility results to help guide their therapy and patient management decisions.

Learn More
BD FACSLyric™ clinical flow cytometry system

Enable powerful, innovative and efficient flow cytometry for your clinical or research lab

Learn More
BD COR™ System

Delivering efficiency, flexibility and performance to meet your laboratories' evolving molecular diagnostic needs.

Learn more
BD Veritor™

Two testing solutions offering reliable results with the same hospital-grade technology that doctors trust.

Learn More

BD Synapsys™

BD Synapsys™ solution enables laboratories to address challenges and improve laboratory outcomes. It enables labs to maximize performance using enhanced microbiology diagnostic informatics through a single, advanced platform with an intuitive, personalized user interface. BD Synapsys solution offers integrated workflow and on-demand insights to empower laboratory staff to impact turnaround time, expedite decision making, improve productivity and simplify compliance.

Learn More
BD HealthSight™ Clinical Advisor and Infection Advisor with MedMined™ Insights

BD HealthSight™ Clinical Advisor and BD HealthSight™ Infection Advisor with MedMined™ Insights are enterprise-wide, e-surveillance and clinical notification solutions allowing users to select the information most actionable for their healthcare site.

Learn More

Sepsis Management

Learn more

Clinical Flow Cytometry

Learn more

Klausing BT, Tillman SD, Wright PW, Talbot TR. The influence of contaminated urine cultures in inpatient and emergency department settings. Am J Infect Control. 2016;44(10):1166-1167. doi: 10.1016/j.ajic.2016.03.055
Data on File: REF-1882 BD Venipuncture Burden Insurance Data, U.S. 2012.
Bryan C. Urinary tract infections. In: Hunt R. Infectious Disease. Microbiology and Immunology On-line. University of South Carolina School of Medicine; 2017. Urinary Tract Infections . Accessed April 17, 2017.
Mitra D, Erdal E, Khangulov V, Tuttle R. Association between laboratory test turnaround time and emergency department length of stay: a retrospective US electronic health database analysis. Poster session presented at: American Association for Clinical Chemistry 2015 Annual Meeting and Clinical Lab Expo; July 26-30, 2015; Atlanta, GA.
Steindel SJ, Howanitz PJ. Physician satisfaction and emergency department laboratory test turnaround time. Arch Pathol Lab Med. 2001;125(7):863-871.
Singh H, Meyer AN, Thomas EJ. The frequency of diagnostic errors in outpatient care: estimations from three large observational studies involving US adult populations. BMJ Qual Saf. 2014;23(9):727-731. doi: 10.1136/bmjqs-2013-002627
Lippi G, Chance JJ, Church S, et al. Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med. 2011;49(7):1113-1126. doi:10.1515/CCLM.2011.600
Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem. 2002;48(5):691-698.
Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States, 2013. https://www.cdc.gov/drugresistance/threat-report-2013. Published September 16, 2013. Accessed September 18, 2018.
Centers for Disease Control and Prevention (CDC). 1 in 3 antibiotic prescriptions unnecessary CDC Newsroom . Last reviewed January 1, 2016. Accessed 18, 2018.
Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. JAMA. 2016;315(17):1864-1873.

Diagnostic Accuracy and Efficiency

Sepsis Management

Clinical Flow Cytometry

Provide your information to download resources